Artery Reclosure and Atherectomy
Links shared publicly online about this topic
AtheroMed initiates enrollment in Phoenix Atherectomy catheter trial for PAD
news-medical.net — “AtheroMed, Inc. announced today the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy" catheter, a minimally invasive device for the treatment of peripheral arterial disease (PAD) in the legs. EASE - Endovascular Atherectomy Safety and Effectiveness - is an FDA-approved Investigational Device Exemption (IDE) clinical trial that will enroll 90 patients at up to 20 clinical sites.” View full resource at news-medical.net
Most Recently Shared on September 7, 2010 at 2:48 pm By:
AtheroMed initiates enrollment in Phoenix Atherectomy catheter trial for PAD: AtheroMed, Inc. announced today the ... http://bit.ly/bWZOL6
AtheroMed, Inc. Announces Launch Of EASE Clinical Trial To Evaluate Peripheral Arterial Disease Treatment
medicalnewstoday.com — “AtheroMed, Inc. announced the start of enrollment in the EASE study to evaluate the safety and effectiveness of the Phoenix Atherectomy™ catheter, a minimally invasive device for the treatme” View full resource at medicalnewstoday.com
Most Recently Shared on September 9, 2010 at 1:00 pm By:
AtheroMed, Inc. Announces Launch Of EASE Clinical Trial To Evaluate Peripheral Arterial Disease Treatment http://mnt.to/3JtB #vascular
Spectranetics Introduces First Advanced System For Simulation Of Peripheral Vascular Arterial Occlusions
medicalnewstoday.com — “Spectranetics Corporation (NASDAQ: SPNC) today announced it will showcase a new advanced peripheral atherectomy simulation system at the New Cardiovascular Horizons meeting in New Orleans. The new” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2011 at 3:07 pm By:
Spectranetics Introduces First Advanced System For Simulation Of Peripheral Vascular Arterial Occlusions http://mnt.to/3WCx #vascular
Strategies for Lower Extremity PAD Compared
newswise.com — “Researchers from Dartmouth-Hitchock Medical Center in Lebanon, N.H. have published a new study in the July issue of the Journal of Vascular Surgery about the trends in lower extremity endovascular interventions (angioplasty and atherectomy), lower extremity bypass surgery and major above and below the knee amputations in Medicare beneficiaries (Part B claims). The study was done between 1996 and 2006.” View full resource at newswise.com
Most Recently Shared on June 30, 2009 at 6:53 pm By:
Strategies for Lower Extremity PAD Compared http://bit.ly/17sCqO
Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study : The Lancet
thelancet.com — “Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. By - Pieter ...” View full resource at thelancet.com
Most Recently Shared on August 26, 2009 at 2:47 am By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Atherectomy and thrombus aspiration before stenting in STEMI - improved outcome at 1 yr - TAPAS trial - http://bit.ly/23a7i0
Spectranetics Announces First Human Uses Of Turbo-Tandem™ System
medicalnewstoday.com — “Spectranetics corporation (nasdaq: spnc) reported the first human procedures using its turbo-tandem™ system, which had earlier received fda clearance and ce mark approval for marketing in th” View full resource at medicalnewstoday.com
Most Recently Shared on July 17, 2009 at 11:15 am By:
MedicalNewsToday: Spectranetics Announces First Human Uses Of Turbo-Tandemâ„¢: http://tinyurl.com/lzkkyz Full http://tinyurl.com/nq3ckl
Research discovery may lead to advances in heart disease and cancer treatment
eurekalert.org — “Research led by T. Cooper Woods, Ph.D., Assistant Professor of Pharmacology and Experimental Therapeutics at LSU Health Sciences Center New Orleans, and Director of the Molecular Cardiology Research Laboratory at Ochsner Clinic Foundation, has identified the mechanism of how a drug commonly used on stents to prevent reclosure of coronary arteries, regulates cell movement which is critical to wound healing and the progression of diseases like cancer. The study is published in the April 16 issue o” View full resource at eurekalert.org
Most Recently Shared on April 14, 2010 at 6:37 pm By:
Tammi Jacobs Health Professional
Research discovery may lead to advances in heart disease and cancer treatment http://bit.ly/bOERlA
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
News-Medical.Net
Medical News from Around the World
-
MNT Vascular
The latest vascular news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Vascular
The latest vascular news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
